Search results for "Aptamer"

showing 10 items of 47 documents

Targeting cancer with peptide aptamers

2011

Renaud Seigneuric 1,2 , Jessica Gobbo 1,2 , Pierre Colas 3 , Carmen Garrido 1,2 1 Heat Shock Proteins and Cancer, INSERM, UMR 866 IFR 100, Faculty of Medicine, 7 Boulevard Jeanne D'Arc, 21000 Dijon, France 2 Universite de Bourgogne, Dijon, France 3 CNRS USR 3151, P2I2 Group, Station Biologique, Roscoff, Bretagne, France Received: June 22, 2011; Accepted: June 24, 2011; Published: June 24, 2011; Correspondence: Renaud Seigneuric, email: // // Abstract A major endeavour in cancer chemotherapy is to develop agents that specifically target a biomolecule of interest. There are two main classes of targeting agents: small molecules and biologics. Among biologics (e.g.: antibodies), DNA, RNA but al…

Cancer chemotherapyAptamermedicine.medical_treatmentRecombinant Fusion ProteinsPeptide Aptamersheat shock proteinAntineoplastic AgentsComputational biologyPharmacologyBiologyTargeted therapy03 medical and health sciences0302 clinical medicineNeoplasmsmedicineHumansNanotechnologyMolecular Targeted TherapyHeat-Shock Proteins030304 developmental biologyCancer0303 health sciencesClinical Trials as TopicCanceraptamerAntineoplastic Protocolsmedicine.diseasetargeted therapypeptide3. Good healthOncology030220 oncology & carcinogenesisResearch PerspectivesAptamers PeptideOncotarget
researchProduct

A Thermophilic Tetramolecular G-Quadruplex/Hemin DNAzyme.

2017

International audience; The quadruplex-based DNAzyme system is one of the most useful artificial enzymes or catalysts; their unique properties make them reliable alternatives to proteins for performing catalytic transformation. The first prototype of a thermally stable DNAzyme system is presented. This thermophilic DNAzyme is capable of oxidizing substrates at high temperatures (up to 95 degrees C) and long reaction times (up to 18 h at 75 degrees C). The catalytic activity of the DNAzymes were investigated with the standard peroxidase-mimicking oxidation of 2,2'-azino-bis(3-ethylbenzothiozoline-6-sulfonic acid) (ABTS) by H2O2. The step-by-step design of this unique heat-activated G-quadrup…

Catalytic transformationDNAzymeoxidationDeoxyribozymeaptamersspecificityNanotechnologyBiocompatible MaterialsdnainsightsG-quadruplex010402 general chemistry[ CHIM ] Chemical Sciences01 natural sciencesperoxidase-mimicking dnazymesCatalysisCatalysischemistry.chemical_compoundOxidizing agent[CHIM]Chemical SciencesBenzothiazolesthermophilicityComputingMilieux_MISCELLANEOUSPeroxidaseChemistry010405 organic chemistryThermophileperoxidase activityGeneral Chemistry[CHIM.CATA]Chemical Sciences/CatalysisGeneral MedicineDNA CatalyticHydrogen PeroxideCombinatorial chemistry0104 chemical sciencesG-QuadruplexesMethylene BluekineticsHeminactivity enhancementSulfonic AcidsporphyrinOxidation-ReductioncomplexHeminAngewandte Chemie (International ed. in English)
researchProduct

Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs

2015

Nucleic acid based drugs (NADBs) are short DNA/RNA molecules that include among others, antisense oligonucleotides, aptamers, small interfering RNAs and micro-interfering RNAs. Despite the different mechanisms of actions, NABDs have the ability to combat the effects of pathological gene expression in many experimental systems. Thus, nowadays, NABDs are considered to have a great therapeutic potential, possibly superior to that of available drugs. Unfortunately, however, the lack of effective delivery systems limits the practical use of NABDs. Due to their hydrophilic nature, NABDs cannot efficiently cross cellular membrane; in addition, they are subjected to fast degradation by cellular and…

Cellular membranePolymersAntisense oligonucleotides aptamers carbon nanotubes exososomes liposomes miRNA polymers siRNAAptamerClinical BiochemistryNanotechnologyAnimals; Humans; Lipids; Nanoparticles; Nanotubes Carbon; Nucleic Acids; Polymers; Drug Delivery SystemsBiologyNanoparticleDrug Delivery SystemsNucleic AcidsAnimalsHumansAvailable drugsPolymerPharmacologyNanotubesNucleic AcidAnimalNanotubes CarbonCarbon chemistryRNALipidLipidsCarbonSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAntisense oligonucleotidesNucleic acidNanoparticlesHuman
researchProduct

Current trends in affinity-based monoliths in microextraction approaches: A review

2019

Abstract This article reviews the research contributions along the past five years concerning to monolithic materials for the development of affinity-based sorbents in the field of microextraction techniques. The first part of this paper includes an introduction regarding monolithic affinity media and information of different binding agents (such as immunoglobulin-binding proteins, enzymes, lectins, antibodies, aptamers, dyes and immobilized metal ions and nanoparticles, among others) that can act as affinity ligands. Then, the preparation of monoliths and ligand immobilization strategies as well as the different available formats (syringes, pipette tips, spin columns, capillaries, disks an…

ChemistryAptamer010401 analytical chemistryMicrofluidicsNanoparticleNanotechnology02 engineering and technologyLigands021001 nanoscience & nanotechnology01 natural sciencesBiochemistryChromatography Affinity0104 chemical sciencesAnalytical ChemistryHumansEnvironmental ChemistrySample preparationAdsorption0210 nano-technologySolid Phase MicroextractionSpectroscopyAnalytica Chimica Acta
researchProduct

Recent advances on nanomaterial based electrochemical and optical aptasensors for detection of cancer biomarkers

2018

Abstract Cancer is a real menace to all societies globally since it is the leading cause of premature mortality in men and women. The incidence of malignancies is enhancing as a result of plenty factors. Physically and economically concerns that occur in cancers patients cannot be neglected. However, current diagnostic methods and cure duration do not fulfill patients requirements. Therefore, it is essential to detect and diagnose cancer biomarkers as soon as possible and overcome the current burdens. Novel aptasensors is emerging as one of the most promising strategies for early recognition of cancer. Aptamers an artificial DNA or RNA sequences, possess plenty of merits such as easy produc…

Diagnostic methodsWeb of sciencebusiness.industryAptamer010401 analytical chemistryEarly detectionCancer02 engineering and technologyComputational biology021001 nanoscience & nanotechnologymedicine.disease01 natural sciences0104 chemical sciencesAnalytical ChemistryBiomarker (cell)MedicineCancer biomarkers0210 nano-technologybusinessSpectroscopyTrAC Trends in Analytical Chemistry
researchProduct

Rupture Force of Single Small Drug Molecule Binding a Split Aptamer

2012

Aptamers are specific oligonucleotides (DNA or RNA) which bind small inorganic or organic molecules, large proteins or cells. In particular, the high affinity of aptamers is expected to lead to a new class of therapeutic reagents. Thus the detection and characterization of binding strength of small molecules is important for drug and medical research. Atomic force spectroscopy (AFS) with a force resolution in the piconewton range is a valuable tool for studying interactions on a single molecular level. The detection of very small target molecules less than 500 Dalton is characterized by only a few hydrogen interactions between the aptamer and the target molecules. Thus tiny rupture forces w…

Dissociation constantAnalyteOligonucleotideChemistryStereochemistryAptamerForce spectroscopyBiophysicsBiophysicsMoleculeBinding siteSmall moleculeBiophysical Journal
researchProduct

DNA Nanostructures in Cell Biology and Medicine

2017

Drug delivery endocytosis DNA aptamers Dip Pen NanolithographyDna nanostructuresDip-pen nanolithographyDrug deliveryNanotechnologyBiologyDNA AptamersEndocytosisCell biology
researchProduct

An aptamer-gated silica mesoporous material for thrombin detection.

2013

An aptamer-capped mesoporous material for the selective and sensitive detection of &-thrombin in human plasma and serum has been prepared and characterised.

INGENIERIA DE LA CONSTRUCCIONSilicon dioxideAptamerInorganic chemistryNanoparticleAptamersCatalysisFluorescencechemistry.chemical_compoundThrombinQUIMICA ORGANICAQUIMICA ANALITICAMaterials ChemistrymedicineElectrochemiluminescenceHumansHuman Alpha-ThrombinElectrochemiluminescenceMagnetic beadssilicon dioxidePropylaminesChemistryRhodaminesQUIMICA INORGANICAMetals and AlloysThrombinGeneral ChemistryAptamers NucleotideSilanesSilicon DioxideFluorescenceSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsSpectrometry FluorescenceHuman plasmaCeramics and CompositesNanoparticlesMesoporous materialNucleotidePorosityColorimetric detectionmedicine.drugNuclear chemistryChemical communications (Cambridge, England)
researchProduct

Fluorogenic Sensing of Carcinogenic Bisphenol A using Aptamer-Capped Mesoporous Silica Nanoparticles

2017

[EN] Mesoporous silica nanoparticles loaded with rhodamine B and capped with a bisphenol A aptamer were used for the selective and sensitive detection of this lethal chemical. The pores of the nanoparticles are selectively opened in the presence of bisphenol A (through its selective coordination with the aptamer) with subsequent rhodamine B delivery. With this capped material a limit of detection as low as 3.5 mu m of bisphenol A was measured.

INGENIERIA DE LA CONSTRUCCIONendocrine systemBisphenol AAptamerMesoporous silica nanoparticlesAptamerNanoparticle02 engineering and technology010402 general chemistryElectron Microscopy Service of the UPV01 natural sciencesCatalysischemistry.chemical_compoundQUIMICA ORGANICAQUIMICA ANALITICARhodamine BOrganic chemistryreproductive and urinary physiologyCarcinogenDetection limiturogenital systemGated nanomaterialsQUIMICA INORGANICAOrganic ChemistryGeneral ChemistryMesoporous silica021001 nanoscience & nanotechnology0104 chemical sciencesBisphenol aFluorogenic sensingchemistry0210 nano-technologyhormones hormone substitutes and hormone antagonistsNuclear chemistryChemistry - A European Journal
researchProduct

Association of neovascular age-related macular degeneration with month and season of birth in Italy

2016

In order to investigate the influence of season and month of birth on the risk of neovascular age-related macular degeneration (n-AMD) in Italy, we evaluated the month birth and sex of all patients, recorded in the anti-vascular endothelial growth factor (VEGF) monitoring registry of the Italian Medicines Agency, born between 1925-1944, who received intravitreal anti-VEGF injections for n-AMD between January 1, 2013 and July 29, 2015. The numbers of all births in Italy in the same years, extracted from the Italian National Institute of Statistics, were used to calculate the expected number of n-AMD cases. Overall, 45,845 patients (19,207 men, 26,638 women) received intravitreal anti-VEGF fo…

MaleVascular Endothelial Growth Factor AAginggenetic structuresMonth of birthVEGF receptorsneovascular AMDAngiogenesis InhibitorsAptamersMacular Degeneration0302 clinical medicineSeason of birthReceptors80 and overMedicineRegistriesAged 80 and overNeovascularization PathologicbiologyVascular Endothelial Growth FactorIncidenceIncidence (epidemiology)Aptamers NucleotideBevacizumabTreatment OutcomeItalyanti-VEGFFemaleSeasonsNucleotideNeovascular age-related macular degenerationResearch Papermedicine.drugAnti-VEGF; Month of birth; Neovascular age-related macular degeneration; Neovascular AMD; Season of birth; Aged; Aged 80 and over; Angiogenesis Inhibitors; Aptamers Nucleotide; Bevacizumab; Female; Humans; Incidence; Italy; Macular Degeneration; Male; Neovascularization Pathologic; Ranibizumab; Receptors Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Registries; Treatment Outcome; Vascular Endothelial Growth Factor A; Seasons; Aging; Cell BiologySeason of birthBevacizumabRecombinant Fusion ProteinsNeovascular AMDneovascular age-related macular degeneration03 medical and health sciencesRanibizumabAge relatedHumansNeovascularizationAgedPathologicseason of birthbusiness.industrymonth of birthAnti-VEGFCell BiologyMacular degenerationmedicine.diseaseeye diseasesanti-VEGF; month of birth; neovascular AMD; neovascular age-related macular degeneration; season of birthReceptors Vascular Endothelial Growth Factor030221 ophthalmology & optometrybiology.proteinsense organsRanibizumabbusinessMonth of birth030217 neurology & neurosurgeryDemographyAging
researchProduct